01—Abstract
Summary
Summary of the 8-K filed June 17, 2025. Cited figures are marked; the original filing is the authoritative source.
Kimco Realty Corporation and its operating partnership, Kimco Realty OP, LLC, entered into an underwriting agreement dated June 16, 2025 with Wells Fargo Securities, LLC, BNP Paribas Securities Corp., PNC Capital Markets LLC, RBC Capital Markets, LLC and Truist Securities, Inc., as representatives of the underwriters.
Under the agreement, Kimco OP agreed to sell $500 milliona aggregate principal amount of its 5.300% Notes due 2036, which the Company will fully and unconditionally guarantee. The pricing press release, furnished as Exhibit 99.1, reports an effective yield of 5.354% and a maturity date of February 1, 2036, with settlement expected on June 26, 2025, subject to customary closing conditions. The notes are being offered under the company's effective shelf registration statement on Form S-3.
Kimco states it intends to use the net proceeds for general corporate purposes, including repaying outstanding borrowings under its $2.0 billionb unsecured revolving credit facility and funding suitable acquisition, investment and redevelopment opportunities. The filing also notes that certain underwriters and their affiliates may have other business relationships with the Company and its subsidiaries in the ordinary course.
For investors, the key facts are the size of the new debt issuance, its pricing and maturity, and the stated use of proceeds, which includes paying down the revolving credit facility. The filing describes the Company as a REIT and owner of grocery-anchored shopping centers, with 567 U.S. shopping centers and mixed-use assets comprising 101 million square feet of gross leasable space as of March 31, 2025.
02—Key points
Key Highlights
- Kimco Realty OP, LLC agreed to sell $500 million of 5.300% Notes due 2036 under an underwriting agreement dated June 16, 2025.
- The notes are fully and unconditionally guaranteed by Kimco Realty Corporation.
- The pricing press release reports an effective yield of 5.354% and a maturity date of February 1, 2036.
- Settlement is expected on June 26, 2025, subject to customary closing conditions.
- Proceeds are intended for general corporate purposes, including repaying borrowings under the $2.0 billion unsecured revolving credit facility and funding acquisition, investment and redevelopment opportunities.
- The offering is made under an effective shelf registration statement on Form S-3 (File Nos. 333-269102 and 333-269102-01).
- As of March 31, 2025, the company owned interests in 567 U.S. shopping centers and mixed-use assets totaling 101 million square feet of gross leasable space.
03—Questions
Frequently Asked Questions
How much debt is Kimco issuing and on what terms?
Kimco OP agreed to sell $500 million aggregate principal amount of 5.300% Notes due 2036, with an effective yield of 5.354% and maturity on February 1, 2036, as stated in the pricing press release. The Company fully and unconditionally guarantees the notes.
What will Kimco do with the net proceeds?
The company intends to use the proceeds for general corporate purposes, including repaying outstanding borrowings under its $2.0 billion unsecured revolving credit facility and funding suitable acquisition, investment and redevelopment opportunities.
When is the offering expected to close?
The offering is expected to settle on June 26, 2025, subject to the satisfaction of customary closing conditions.
Who are the underwriters for the offering?
The underwriting agreement is with Wells Fargo Securities, LLC, BNP Paribas Securities Corp., PNC Capital Markets LLC, RBC Capital Markets, LLC and Truist Securities, Inc., as representatives of the several underwriters. The pricing press release also lists additional joint book-running managers, senior co-managers and co-managers.
How is the notes offering being registered?
The notes are offered pursuant to an effective shelf registration statement on Form S-3 (File Nos. 333-269102 and 333-269102-01), with a base prospectus and related prospectus supplement.
04—Continue